Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates. Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium. For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register. For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
1537116
Title:
PYRAZOLOPYRIMIDINES UTILISABLE POUR LE TRAITEMENT DES MALADIES CANCEREUSES
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic information
Application number:
037945920
WO application number:
US2003027555
Type:
European patent granted for BE
Status:
Expired
Publication number:
1537116
WO publication number:
WO 2004/022561
1rst applicant's nationality:
Translation language:
French
EPO publication language:
English
SPC number:
Dates
Filing date:
03/09/2003
Grant date:
02/06/2010
EP publication date:
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
24/08/2010
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
02/06/2010
EP B1 publication date:
02/06/2010
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
03/09/2023
Applicant
1
Name:
Pharmacopeia, LLC
Legal Form:
From:
02/08/2012
Address:
10275 Science Center Drive, San Diego CA 92121, United States (US)
To:
2
Name:
Merck Sharp & Dohme LLC
Legal Form:
From:
18/10/2022
Address:
126 East Lincoln Avenue, P.O. Box 2000, Rahway, New Jersey 07065, United States (US)
To:
3
Name:
PHARMACOPEIA LLC
Legal Form:
From:
02/06/2010
Address:
-, -, Unknown (UNKNOWN)
To:
02/08/2012
4
Name:
SCHERING CORP.
Legal Form:
From:
02/06/2010
Address:
-, -, Unknown (UNKNOWN)
To:
02/08/2012
5
Name:
Merck Sharp & Dohme Corp.
Legal Form:
From:
02/08/2012
Address:
126 East Lincoln Avenue, Rahway New Jersey 07065, United States (US)
To:
18/10/2022
Agent
1
Name:
POLVERARI Luca
Legal Form:
From:
01/08/2019
Address:
44, rue de la Vallée
B.P. 1775, 1017, LUXEMBOURG, Luxembourg (LU)